SOPHiA GENETICS (SOPH) Total Debt (2020 - 2025)

SOPHiA GENETICS's (SOPH) quarterly Total Debt came in at $47.7 million in Q4 2025, up 260.6% year-on-year from $13.2 million in Q4 2024, and little changed quarter-over-quarter from $47.6 million in Q3 2025.

SOPHiA GENETICS (SOPH) Total Debt (2020 - 2025) Analysis & Trends

SOPHiA GENETICS has disclosed Total Debt across 3 years of filings, most recently posting $47.7 million for Q4 2025.

  • Total Debt for Q4 2025 came in at $47.7 million, up 260.6% year-over-year; the trailing twelve-month figure through Dec 2025 was $47.7 million (up 260.6% YoY), and the FY2025 annual result was $47.7 million, up 260.6% from the prior year.
  • Total Debt came in at $47.7 million for Q4 2025 at SOPHiA GENETICS, roughly flat from $47.6 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $47.7 million in Q4 2025 to a low of $13.2 million in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Veeva Systems 24.83 Bn 17.52 Bn 662.02 Mn -
2 BrightSpring Health Services 13.57 Bn 12.69 Bn 482.22 Mn 2.50 Bn
3 Healthequity 7.20 Bn 6.93 Bn 256.31 Mn 942.66 Mn
4 Hinge Health 5.42 Bn 5.11 Bn 154.23 Mn -
5 10x Genomics 4.46 Bn 3.92 Bn 106.18 Mn -
6 Doximity 3.81 Bn 3.06 Bn 125.97 Mn -
7 Waystar Holding 3.52 Bn 3.36 Bn 268.04 Mn 1.47 Bn
8 Privia Health 2.94 Bn 2.57 Bn 595.71 Mn -
9 Omnicell 1.76 Bn 1.59 Bn 140.36 Mn -
10 SOPHiA GENETICS 26.19 Mn -44.10 Mn 14.69 Mn 47.73 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 47.73 Mn
Sep 30, 2025 47.58 Mn
Jun 30, 2025 47.47 Mn
Mar 31, 2025 13.32 Mn
Dec 31, 2024 13.24 Mn
Sep 30, 2024 13.16 Mn
Jun 30, 2024 13.34 Mn
Dec 31, 2020 3.33 Mn